Lipoprotein distribution of a novel endotoxin antagonist, E5531, in plasma from human subjects with various lipid levels

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 10, 1999, Pages 2562-2564

  Wasan, Kishor M ^a   Strobel, Frank W ^a   Parrott, Steven C ^a   Lynn, Melvyn ^b   Christ, William J ^b   Hawkins, Lynn D ^c   Rossignol, Daniel P ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b EISAI INC   (United States)

^c EISAI RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; E 5531; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; DRUG BINDING; DRUG DISTRIBUTION; LIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPSIS;

EID: 0032823099     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.10.2562     Document Type: Article

References (12)

1. Alvares, C., and A. Ramos. 1986. Lipids, lipoproteins, and apoproteins in serum during infection. Clin. Chem. 32:142-145.
2. Cassidy, S. M., F. W. Strobel, and K. M. Wasan. 1998. Plasma lipoprotein distribution of liposomal nystatin is influenced by protein content of high-density lipoproteins. Antimicrob. Agents Chemother. 42:1878-1888.
3. Davis, R. A., and J. E. Vance. 1996. Structure, assembly and secretion of lipoproteins, p. 473-493. In D. E. Vance and J. E. Vance (ed.), Biochemistry of lipids, lipoproteins and membranes. Elsevier, New York, N.Y.
4. Davis, R. A. 1991. Lipoprotein structure and secretion, p. 403-426. In D. E. Vance and J. E. Vance (ed.), Biochemistry of lipids, lipoproteins and membranes. Elsevier, New York, N.Y.
5. Feingold, K. R., R. M. Krauss, M. Pang, et al. 1993. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low-density lipoprotein subclass pattern. J. Clin. Endocrinol. Metab. 76:1423-1431.
6. Grunfeld, C., M. Pang, W. Doerrler, et al. 1992. Lipids, lipoproteins, triglyceride clearance and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J. Clin. Endocrinol. Metab. 74:2045-2051.
7. Rose, J., M. Mullarkey, W. J. Christ, L. D. Hawkins, M. Lynn, Y. Kishi, K. M. Wasan, K. Peteherych, and D. P. Rossignol. Unpublished data. 7a.Rose, J., et al. Unpublished observations.
8. Umeki, S. 1993. Decreases in serum cholesterol levels in advanced lung cancer. Respiration 60:178-181.
9. Vitols, S., G. Gahrton, M. Bjorkholm, and C. Peterson. 1985. Hypocholesterolemia in malignancy due to elevated low-density-lipoprotein-receptor activity in tumor cells: evidence from studies in patients with leukemia. Lancet iv:1150-1154.
10. Wasan, K. M., S. M. Cassidy, M. Ramaswamy, A. Kennedy, F. W. Strobel, S. P. Ng, and T. P. Lee. 1999. A comparison of step-gradient and sequential density ultracentrifugation and the use of lipoprotein deficient plasma controls in determining the plasma lipoprotein distribution of lipid-associated nystatin and cyclosporine. Pharm. Res. 16:165-169.
11. Wasan, K. M., and G. Lopez-Berestein. 1995. Targeted liposomes in fungi: modifying the therapeutic index of amphotericin B by its incorporation into negatively charged liposomes. J, Liposome Res. 5:883-903.
12. Wasan, K. M., V. B. Grossie, Jr., and G. Lopez-Berestein. 1994. Concentrations in serum and tissue distribution of free and liposomal amphotericin B in rats during continuous Intralipid infusion. Antimicrob. Agents Chemother. 38:2224-2226.